Sequent Scientific Limited

SEQUENT

INE807F01027

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 11:00:52 14/06/2024 BST			5-day change	1st Jan Change
122.8 ^INR	-0.49%		+2.29%	+7.91%

05-16	Sequent Scientific Limited Seeks M&A	CI
05-16	Transcript : Sequent Scientific Limited, Q4 2024 Earnings Call, May 16, 2024

Sequent Scientific Limited Announces Appointment of Rajaram Narayanan as Chief Executive Officer

April 10, 2022 at 03:36 pm

Sequent Scientific Limited announced the appointment of Mr. Rajaram Narayanan as Chief Executive Officer, by Postal Ballot seeking the consent of the members.

Latest news about Sequent Scientific Limited

Sequent Scientific Limited Seeks M&A	05-16	CI
Transcript : Sequent Scientific Limited, Q4 2024 Earnings Call, May 16, 2024	05-16
Sequent Scientific Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-15	CI
Sequent Scientific Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-15	CI
Sequent Scientific's Joint Managing Director Resigns	04-04	MT
Sequent Scientific Limited Announces Resignation of Sharat Pandurang Narasapur, Jt. Managing Director, from the Board of Directors, Member of the Corporate Social Responsibility Committee of the Board Effective on April 30, 2024	04-04	CI
Transcript : Sequent Scientific Limited, Q3 2024 Earnings Call, Feb 15, 2024	02-15
Sequent Scientific Limited Announces Executive Changes	02-13	CI
Sequent Scientific Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
Sequent Scientific Limited Announces Resignation of Krunal Shah as Company Secretary & Compliance Officer, Effective on February 15, 2024	12-06	CI
Sequent Scientific Appoints CFO	11-07	MT
Transcript : Sequent Scientific Limited, Q2 2024 Earnings Call, Nov 07, 2023	11-07
Sequent Scientific's CFO Resigns	17/10/23	MT
Sequent Scientific Limited Announces Patri Venkat Raghavendra Rao as Chief Financial Officer	16/10/23	CI
Transcript : Sequent Scientific Limited, Q1 2024 Earnings Call, Aug 11, 2023	11/08/23
Sequent Scientific Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23	CI
Sequent Scientific Discontinues Manufacturing Operations at Tarapur Unit in India	17/07/23	MT
Sequent Scientific Limited Announces Discontinuation of Manufacturing Operations At Tarapur, Maharashtra	14/07/23	CI
Transcript : Sequent Scientific Limited, Q4 2023 Earnings Call, May 24, 2023	24/05/23
Sequent Scientific Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23/05/23	CI
INDIA STOCKS-Indian shares fall on rate fears after Powell reiterates hawkish message	09/03/23	RE
SeQuent Scientific Terminates Agreement to Acquire Tineta Pharma	09/03/23	MT
Indian shares set for muted start as Powell reiterates hawkish message	09/03/23	RE
Sequent Scientific Limited cancelled the acquisition of Tineta Pharma Private Limited from group of shareholders.	07/03/23	CI
Transcript : Sequent Scientific Limited, Q3 2023 Earnings Call, Feb 15, 2023	15/02/23

Chart Sequent Scientific Limited

Duration

Period

More charts

SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. Its subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.

Sector

Pharmaceuticals

Calendar

07/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SEQUENT SCIENTIFIC LIMITED	+7.91%	365M
NOVO NORDISK A/S	+41.96%	630B
JOHNSON & JOHNSON	-7.15%	350B
MERCK & CO., INC.	+18.77%	328B
ABBVIE INC.	+8.79%	298B
ASTRAZENECA PLC	+18.02%	246B
ROCHE HOLDING AG	+1.27%	225B
NOVARTIS AG	+11.95%	218B
AMGEN INC.	+3.68%	160B
PFIZER, INC.	-4.38%	156B

Other Pharmaceuticals